Positive new data suggests that more people facing advanced breast cancer may be able to put off treatment with harsh ...

which indicates whether your breast tumor tissue sample came up as HER2-positive or HER2-negative. The specific test within the report that determines your HER2 status is called an ...

But having treated breast cancer and seeing the drug development, I think people with Her2-positive breast cancer should be encouraged to know that we have drugs that increase the cure rate ...

The treatment landscape for HER2-positive disease appears “optimistic.” Continued research is needed to understand the mechanisms of resistance to HER2-directed therapies. Tremendous progress ...

HER2+ breast cancer usually undergo pre-operative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery.

Enhertu is already approved as a second-line or later therapy for HER2-positive breast cancer based on the results of the DESTINY-Breast03 trial, as well as several other indications, including HR ...

Some patients with HER2-positive breast cancer can reduce the intensity of adjuvant chemotherapy while maintaining the full benefits in terms of prognosis, new data suggest. Lowering the intensity ...

Young patients with HER2-positive breast cancer face unique concerns when diagnosed. Controlling for other known prognostic factors, young patients have similar outcomes as older patients.

HER2-negative and HER2-positive are types of breast cancer that share some things in common, but they have plenty of differences, too. Which kind you have can affect the treatment you get.

What Is HER2-Positive Breast Cancer? HER2-positive breast cancer is when breast cancer cells have a protein receptor called human epidermal growth factor receptor 2 (HER2). Normally, this protein ...

But too much HER2 can trigger cells to grow out of control. HER2-positive breast cancer happens when the HER2 gene in your DNA mutates (changes) and makes extra copies of the genes that make the ...